reports
SuRo Capital Corp. Third Quarter 2025 Preliminary Investment Portfolio...
SuRo Capital Corp. Third Quarter 2025 Preliminary Investment Portfolio Update Net Asset Value Anticipated to be $9.00 to $9.50 Per Share Invests $5 Million in HYPE via HL Digital Assets, Inc. Strong Portfolio Momentum Continues to be Driven by AI and AI Infrastructure Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ) today provided the following preliminary update on its investment portfolio for the third quarter ended September 30, 2025. “As previously highlighted, our record second quarter growth was driven by ...
Bassett Reports Fiscal Year 2025 Third Quarter Results
Bassett Reports Fiscal Year 2025 Third Quarter Results BASSETT, Va., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) reported today its results of operations for its third quarter ended August 30, 2025. Q3 Consolidated Business Highlights: [FY 25 vs. FY 24, unless otherwise specified] Revenues increased 5.9% from the prior year quarter. Excluding sales from Noa Home Inc., which closed in late 2024, consolidated revenues increased 7.3%.Operating income was $0.6 million, or 0.7% of sales as compared to a loss of $(6.4) million for the prior year quarte...
MediciNova to Present at the LD Micro Main Event XIX Investor Conferen...
MediciNova to Present at the LD Micro Main Event XIX Investor Conference LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, M.D., Ph.D., President and CEO, and David H. Crean, Ph.D., Chief Business Officer, will present a corporate overview at the LD Micro Main Event XIX Investor Conference. The conference is being held on October 19 – 22, 2025 at the Hotel Del Coronado in San ...
Simply Good Foods to Report Fourth Quarter and Full Fiscal Year 2025 F...
Simply Good Foods to Report Fourth Quarter and Full Fiscal Year 2025 Financial Results on Thursday, October 23, 2025 DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced it will report financial results for its Fourth Quarter and Fiscal Year 2025 on Thursday, October 23, 2025. A press release will be issued that morning, followed by a live conference call beginning at 6:30 a.m. Mountain Time (8:30 a.m. Eastern Time). Participating on the call will be Geo...
Bassett Announces Third Quarter Conference Call
Bassett Announces Third Quarter Conference Call BASSETT, Va., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) today announced it will host a conference call with management on Thursday, October 9, 2025, at 9:00 a.m. ET to discuss its third quarter 2025 financial results. The Company will issue its earnings release after the market closes on Wednesday, October 8, 2025. Rob Spilman, Chairman and CEO will host the call, along with Mike Daniel, Senior Vice President and CFO. The public is invited to listen to the conference call by webcast, accessible thr...
KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial ...
KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint -- Study did not meet primary endpoint of complete healing of PCED at Week 8; secondary endpoints also did not achieve statistical significance -- -- KPI-012 was well-tolerated with no treatment-related serious adverse events observed -- -- KALA to cease clinical development of KPI-012, preserve cash and explore strategic options -- ARLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, In...
Williams Sonoma Inc: 1 director
A director at Williams Sonoma Inc sold 3,500 shares at 198.790USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Winnebago Industries to Announce Fourth Quarter and Fiscal 2025 Financ...
Winnebago Industries to Announce Fourth Quarter and Fiscal 2025 Financial Results on October 22, 2025 EDEN PRAIRIE, Minn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor recreation product manufacturer, plans to issue its fourth quarter and fiscal 2025 financial results before the opening of the New York Stock Exchange on Wednesday, October 22, 2025. At 9:00 a.m. CT, the Company will conduct a conference call hosted by Michael Happe, President and Chief Executive Officer, and Bryan Hughes, Senior Vice President and Chief Financial Officer. Yo...
Stitch Fix to Participate in 2025 Global Consumer & Retail Conference
Stitch Fix to Participate in 2025 Global Consumer & Retail Conference SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that management will participate in the 2025 Global Consumer & Retail Conference hosted by Telsey Advisory Group in collaboration with Santander Corporate & Investment Banking. 2025 Global Consumer & Retail ConferenceNew York City, NYWednesday, October 8, 2025Fireside Chat at 11:10 a.m. ET A live webcast and replay of the session will be available on the investor relations sect...
Stitch Fix Announces Fourth Quarter and Full Fiscal Year 2025 Financia...
Stitch Fix Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results Q4 2025 Net Revenue Decreased 2.6% YoY, Increased 4.4% YoY on a 13-Week Adjusted BasisQ4 2025 Net Revenue Per Active Client Grew 3.0% YoY to $549FY 2025 Gross Margin Expanded YoY to 44.4% SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today announced its financial results for the fourth quarter and full fiscal year 2025, ended August 2, 2025. Please note that fiscal 2024 was a 53-week year due to an extra week in the fourth q...
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial ...
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND LA JOLLA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding the Phase 2b/3 COMBAT clinical trial of MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) patients has been selected for a poster presentation at 36th International Symposium on ALS/MND to be held December ...
Hershey RV Show Marks Multiple New RV Models and Breakthrough Technolo...
Hershey RV Show Marks Multiple New RV Models and Breakthrough Technologies for Winnebago Industries’ Premium RV Portfolio EDEN PRAIRIE, Minn., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor recreation product manufacturer, will debut several new models and cutting edge innovations across its industry-leading lineup of premium RV brands at the in Hershey, Pa., Sept. 10-14, 2025. Winnebago Industries’ brands will feature over 120 models, host test drive opportunities and have experts on site to help attendees select the perfect RV for their nex...
MediciNova Provides Shareholder Update on Key Developments
MediciNova Provides Shareholder Update on Key Developments LA JOLLA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), provides a shareholder update recapping important developments for the Company. Standby Equity Purchase Agreement (SEPA) The Company reported the signing of a Standby Equity Purchase Agreement (SEPA) for up to $30 million worth of common stock over the course of 36 months. Under that Agr...
Stitch Fix Inc: 1 director
A director at Stitch Fix Inc sold 152,355 shares at 5.061USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Stitch Fix Announces Date for Fourth Quarter and Full Fiscal Year 2025...
Stitch Fix Announces Date for Fourth Quarter and Full Fiscal Year 2025 Financial Results and Conference Call SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its fourth quarter and full fiscal year 2025 ended August 2, 2025 after market close on Wednesday, September 24, 2025. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and Da...
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment C...
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference ARLINGTON, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that members of management will present at the H.C. Wainwright 27th Annual Global Investment Conference being held in New York, NY on Wednesday, September 10, 2025 at 2:00 p.m. ET. Management will be available for one-on-one meetings on Wednesday,...
MediciNova to Present at the H.C. Wainwright 27th Annual Global Invest...
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, MD., Ph.D., President and CEO, and David H. Crean, PhD, Chief Business Officer will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference. The conference is being held on September 8 – 10, 2025 at the Lot...
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer ...
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director Mr. Bazemore brings over 30 years of extensive leadership experience in the biopharmaceutical industry with a focus on growing rare disease companies ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that Todd Bazemore has been named President and Chief Executive Officer (CEO) of KALA BIO an...
- Dave Nicoski
- Ross LaDuke
PBF PBF ENERGY INC. CLASS A
LEN LENNAR CORPORATION CLASS A
GPRE GREEN PLAINS INC.
GBCI GLACIER BANCORP INC.
FFIC FLUSHING FINANCIAL CORP.
DVN DEVON ENERGY CORPORATION
DECK DECKERS OUTDOOR CORPORATION
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CNO CNO FINANCIAL GROUP INC.
CBU COMMUNITY BANK SYSTEM INC.
BIIB BIOGEN INC.
BC BRUNSWICK CORPORATION
HP HELMERICH & PAYNE INC.
PVH PVH CORP.
TTC TORO COMPANY
HOG HARLEY-DAVIDSON INC.
WGO WINNEBAGO INDUSTRIES INC.
APLS APELLIS PHARMACEUTICALS
PRPL PURPLE INNOVATION
GRWG GROWGENERATION
DCOM DIME COMMUNITY BANCSHARES INC
APA APA CORPORATION
AMR ALPHA METALLURGICAL RESOURCES INC
BBWI BATH & BODY WORKS INC
CIVI CIVITAS RESOURCES INC
BORR BORR DRILLING LTD
MBC_w MASTERBRAND INC
NE NOBLE CORP (NEW)
FTREV FORTREA HOLDINGS INC.
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that it successfully achieved enrollment of the target number of participants in its COMBAT-ALS Phase 2b/3 clinical trial of MN-166 (ibudilast). MN-166 is currently in development for the treatment of Amyotrophic Lateral Sclerosis (ALS). Dr. Yuichi Iwaki, MediciNova President and CEO commented, “This m...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.